NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients

Arif N. Ali, Peixin Zhang, W. K.Alfred Yung, Yuhchyau Chen, Benjamin Movsas, Raul C. Urtasun, Christopher U. Jones, Kwang N. Choi, Jeff M. Michalski, A. Jennifer Fischbach, Arnold M. Markoe, Christopher J. Schultz, Marta Penas-Prado, Madhur K. Garg, Alan C. Hartford, Harold E. Kim, Minhee Won, Walter J. Curran

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients'. Together they form a unique fingerprint.

Medicine & Life Sciences